Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-30

Clinical Trial Update: Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating maintenance treatment with resminostat in patients with advanced mycosis fungoides or Sézary syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Resminostat (resminostat)

Snippet

Sponsor: 4SC AG | Conditions: Mycosis Fungoides, Sezary Syndrome | Phase 2 | Status: COMPLETED